BHM vs VRTX · rev $50.2M vs P/E 30, rev $12.00B
Bluerock Homes Trust Inc. (BHM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Bluerock Homes Trust Inc. (BHM) is a reit - residential company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported BHM revenue for 2024-12-31 was $50.2M. Net income was -$12.1M. Revenue was up 22.2% from 2023-12-31 to 2024-12-31. BHM currently screens at market cap $40.1M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
BHM currently screens at market cap $40.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the BHM and VRTX stock pages for the full models.
Not investment advice.